The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2025 | Focusing on patient experience and future treatment developments in pancreatic cancer
Efrat Dotan, MD, Fox Chase Cancer Center, Philadelphia, PA, discusses exciting developments in pancreatic cancer treatments. While no practice-changing therapies have emerged, Dr Dotan praises the significant emphasis placed on enhancing the patient experience and understanding patient-reported outcomes. By addressing the unique needs of patients with pancreatic cancer, novel research could lead to more effective treatments and improved therapeutic outcomes. This interview took place at the ASCO GI Cancers Symposium 2025 in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
